Premier Biomedical, Inc. (OTCMKTS:BIEI) Sees Significant Increase in Short Interest

Premier Biomedical, Inc. (OTCMKTS:BIEI) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 80,300 shares, an increase of 101.8% from the February 28th total of 39,800 shares. Based on an average daily trading volume, of 5,645,000 shares, the short-interest ratio is currently 0.0 days.

Premier Biomedical Stock Down 20.0 %

Shares of BIEI traded down $0.00 during trading hours on Friday, hitting $0.00. The stock had a trading volume of 1,445,672 shares, compared to its average volume of 3,843,335. Premier Biomedical has a 12 month low of $0.00 and a 12 month high of $0.00.

About Premier Biomedical

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors.